BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 10036239)

  • 1. Homotypic and heterotypic interaction of the neurofibromatosis 2 tumor suppressor protein merlin and the ERM protein ezrin.
    Grönholm M; Sainio M; Zhao F; Heiska L; Vaheri A; Carpén O
    J Cell Sci; 1999 Mar; 112 ( Pt 6)():895-904. PubMed ID: 10036239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction between two isoforms of the NF2 tumor suppressor protein, merlin, and between merlin and ezrin, suggests modulation of ERM proteins by merlin.
    Meng JJ; Lowrie DJ; Sun H; Dorsey E; Pelton PD; Bashour AM; Groden J; Ratner N; Ip W
    J Neurosci Res; 2000 Nov; 62(4):491-502. PubMed ID: 11070492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurofibromatosis 2 tumor suppressor protein colocalizes with ezrin and CD44 and associates with actin-containing cytoskeleton.
    Sainio M; Zhao F; Heiska L; Turunen O; den Bakker M; Zwarthoff E; Lutchman M; Rouleau GA; Jääskeläinen J; Vaheri A; Carpén O
    J Cell Sci; 1997 Sep; 110 ( Pt 18)():2249-60. PubMed ID: 9378774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hierarchy of merlin and ezrin N- and C-terminal domain interactions in homo- and heterotypic associations and their relationship to binding of scaffolding proteins EBP50 and E3KARP.
    Nguyen R; Reczek D; Bretscher A
    J Biol Chem; 2001 Mar; 276(10):7621-9. PubMed ID: 11106646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Universal absence of merlin, but not other ERM family members, in schwannomas.
    Stemmer-Rachamimov AO; Xu L; Gonzalez-Agosti C; Burwick JA; Pinney D; Beauchamp R; Jacoby LB; Gusella JF; Ramesh V; Louis DN
    Am J Pathol; 1997 Dec; 151(6):1649-54. PubMed ID: 9403715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression level, subcellular distribution and rho-GDI binding affinity of merlin in comparison with Ezrin/Radixin/Moesin proteins.
    Maeda M; Matsui T; Imamura M; Tsukita S; Tsukita S
    Oncogene; 1999 Aug; 18(34):4788-97. PubMed ID: 10490812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Merlin differentially associates with the microtubule and actin cytoskeleton.
    Xu HM; Gutmann DH
    J Neurosci Res; 1998 Feb; 51(3):403-15. PubMed ID: 9486775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ezrin self-association involves binding of an N-terminal domain to a normally masked C-terminal domain that includes the F-actin binding site.
    Gary R; Bretscher A
    Mol Biol Cell; 1995 Aug; 6(8):1061-75. PubMed ID: 7579708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Merlin differs from moesin in binding to F-actin and in its intra- and intermolecular interactions.
    Huang L; Ichimaru E; Pestonjamasp K; Cui X; Nakamura H; Lo GY; Lin FI; Luna EJ; Furthmayr H
    Biochem Biophys Res Commun; 1998 Jul; 248(3):548-53. PubMed ID: 9703963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interdomain interaction of merlin isoforms and its influence on intermolecular binding to NHE-RF.
    Gonzalez-Agosti C; Wiederhold T; Herndon ME; Gusella J; Ramesh V
    J Biol Chem; 1999 Nov; 274(48):34438-42. PubMed ID: 10567424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of molecular domains of epitope-tagged merlin isoforms in Cos-7 cells and primary rat Schwann cells.
    Xu L; Gonzalez-Agosti C; Beauchamp R; Pinney D; Sterner C; Ramesh V
    Exp Cell Res; 1998 Jan; 238(1):231-40. PubMed ID: 9457076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The neurofibromatosis 2 protein product merlin selectively binds F-actin but not G-actin, and stabilizes the filaments through a lateral association.
    James MF; Manchanda N; Gonzalez-Agosti C; Hartwig JH; Ramesh V
    Biochem J; 2001 Jun; 356(Pt 2):377-86. PubMed ID: 11368764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localization and functional domains of the neurofibromatosis type II tumor suppressor, merlin.
    Shaw RJ; McClatchey AI; Jacks T
    Cell Growth Differ; 1998 Apr; 9(4):287-96. PubMed ID: 9563848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the NF2 protein merlin and the ERM protein ezrin in human, rat, and mouse central nervous system.
    Grönholm M; Teesalu T; Tyynelä J; Piltti K; Böhling T; Wartiovaara K; Vaheri A; Carpén O
    Mol Cell Neurosci; 2005 Apr; 28(4):683-93. PubMed ID: 15797715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NHE-RF, a regulatory cofactor for Na(+)-H+ exchange, is a common interactor for merlin and ERM (MERM) proteins.
    Murthy A; Gonzalez-Agosti C; Cordero E; Pinney D; Candia C; Solomon F; Gusella J; Ramesh V
    J Biol Chem; 1998 Jan; 273(3):1273-6. PubMed ID: 9430655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurofibromatosis 2 tumour suppressor schwannomin interacts with betaII-spectrin.
    Scoles DR; Huynh DP; Morcos PA; Coulsell ER; Robinson NG; Tamanoi F; Pulst SM
    Nat Genet; 1998 Apr; 18(4):354-9. PubMed ID: 9537418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neurofibromatosis type 2 (NF2)].
    Araki N; Takeshima H; Saya H
    Gan To Kagaku Ryoho; 1997 Sep; 24(11):1427-31. PubMed ID: 9309136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of EBP50: A PDZ-containing phosphoprotein that associates with members of the ezrin-radixin-moesin family.
    Reczek D; Berryman M; Bretscher A
    J Cell Biol; 1997 Oct; 139(1):169-79. PubMed ID: 9314537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding of the merlin-I product of the neurofibromatosis type 2 tumour suppressor gene to a novel site in beta-fodrin is regulated by association between merlin domains.
    Neill GW; Crompton MR
    Biochem J; 2001 Sep; 358(Pt 3):727-35. PubMed ID: 11535133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional analysis of the neurofibromatosis type 2 protein by means of disease-causing point mutations.
    Stokowski RP; Cox DR
    Am J Hum Genet; 2000 Mar; 66(3):873-91. PubMed ID: 10712203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.